Does ELTROMBOPAG Cause Disease progression? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Disease progression have been filed in association with ELTROMBOPAG. This represents 2.4% of all adverse event reports for ELTROMBOPAG.
130
Reports of Disease progression with ELTROMBOPAG
2.4%
of all ELTROMBOPAG reports
75
Deaths
32
Hospitalizations
How Dangerous Is Disease progression From ELTROMBOPAG?
Of the 130 reports, 75 (57.7%) resulted in death, 32 (24.6%) required hospitalization, and 4 (3.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG Cause?
Platelet count decreased (968)
Death (629)
Drug ineffective (554)
Product use in unapproved indication (303)
Thrombocytopenia (262)
Off label use (255)
Headache (229)
Pyrexia (229)
Haemoglobin decreased (213)
Pneumonia (204)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ELTROMBOPAG Alternatives Have Lower Disease progression Risk?
ELTROMBOPAG vs ELTROMBOPAG OLAMINE
ELTROMBOPAG vs ELUXADOLINE
ELTROMBOPAG vs ELVITEGRAVIR
ELTROMBOPAG vs EMAPALUMAB
ELTROMBOPAG vs EMAPALUMAB-LZSG